{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T03:59:31Z","timestamp":1769572771524,"version":"3.49.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,4,17]],"date-time":"2018-04-17T00:00:00Z","timestamp":1523923200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,4,17]],"date-time":"2018-04-17T00:00:00Z","timestamp":1523923200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Gastroenterol Rep"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1007\/s11894-018-0621-1","type":"journal-article","created":{"date-parts":[[2018,4,17]],"date-time":"2018-04-17T03:37:16Z","timestamp":1523936236000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Health Maintenance in Inflammatory Bowel Disease"],"prefix":"10.1007","volume":"20","author":[{"given":"Fazia A.","family":"Mir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunanda V.","family":"Kane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,4,17]]},"reference":[{"key":"621_CR1","doi-asserted-by":"crossref","unstructured":"Kaplan GG, Ng SC. Understanding and preventing the global increase of inflammatory bowel disease. Gastroenterology 2017;152(2):313\u2013321 e2.","DOI":"10.1053\/j.gastro.2016.10.020"},{"key":"621_CR2","doi-asserted-by":"crossref","unstructured":"\u2022 Selby L, Kane S, Wilson J, Balla P, Riff B, Bingcang C, et al. Receipt of preventive health services by IBD patients is significantly lower than by primary care patients. Inflamm Bowel Dis. 2008; 14(2):253\u20138. The first article published before the widespread use of biologics for IBD to address an issue that had not been recognized previously.","DOI":"10.1002\/ibd.20266"},{"issue":"9","key":"621_CR3","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1002\/ibd.20944","volume":"15","author":"M Moscandrew","year":"2009","unstructured":"Moscandrew M, Mahadevan U, Kane S. General health maintenance in IBD. Inflamm Bowel Dis. 2009;15(9):1399\u2013409.","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"621_CR4","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1586\/17474124.2014.934672","volume":"9","author":"AP Desalermos","year":"2015","unstructured":"Desalermos AP, Farraye FA, Wasan SK. Vaccinating the inflammatory bowel disease patient. Expert Rev Gastroenterol Hepatol. 2015;9(1):91\u2013102.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"621_CR5","unstructured":"Reich J, Wasan S, Farraye FA. Vaccinating patients with inflammatory bowel disease. Gastroenterol Hepatol (N Y). 2016; 12(9):540\u2013546."},{"issue":"6","key":"621_CR6","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1038\/ajg.2009.733","volume":"105","author":"SK Wasan","year":"2010","unstructured":"Wasan SK, Baker SE, Skolnik PR, Farraye FA. A practical guide to vaccinating the inflammatory bowel disease patient. Am J Gastroenterol. 2010;105(6):1231\u20138.","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"621_CR7","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1093\/ecco-jcc\/jjv064","volume":"9","author":"G Malhi","year":"2015","unstructured":"Malhi G, Rumman A, Thanabalan R, Croitoru K, Silverberg MS, Hillary Steinhart A, et al. Vaccination in inflammatory bowel disease patients: attitudes, knowledge, and uptake. J Crohns Colitis. 2015;9(6):439\u201344.","journal-title":"J Crohns Colitis"},{"issue":"1","key":"621_CR8","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/ibd.21666","volume":"18","author":"GY Melmed","year":"2012","unstructured":"Melmed GY. Immunizations and IBD: whose responsibility is it? If I\u2019m the prescribing doctor, shouldn\u2019t it be mine? Inflamm Bowel Dis. 2012;18(1):41\u20132.","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"621_CR9","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1093\/cid\/cit816","volume":"58","author":"LG Rubin","year":"2014","unstructured":"Rubin LG, Levin MJ, Ljungman P, Davies EG, Avery R, Tomblyn M, et al. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis. 2014;58(3):309\u201318.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"621_CR10","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1097\/00054725-200409000-00028","volume":"10","author":"BE Sands","year":"2004","unstructured":"Sands BE, Cuffari C, Katz J, Kugathasan S, Onken J, Vitek C, et al. Guidelines for immunizations in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2004;10(5):677\u201392.","journal-title":"Inflamm Bowel Dis"},{"issue":"8","key":"621_CR11","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1097\/MIB.0000000000000395","volume":"21","author":"MD Long","year":"2015","unstructured":"\u2022 Long MD, Gulati A, Wohl D, Herfarth H. Immunizations in pediatric and adult patients with inflammatory bowel disease: a practical case-based approach. Inflamm Bowel Dis. 2015;21(8):1993\u20132003. A practical clinically relevant article that can help clinicians at the bedside decide what vaccines are appropriate for their patients","journal-title":"Inflamm Bowel Dis"},{"key":"621_CR12","doi-asserted-by":"publisher","first-page":"43","DOI":"10.2147\/CEG.S42514","volume":"6","author":"DJ Stobaugh","year":"2013","unstructured":"Stobaugh DJ, Deepak P, Ehrenpreis ED. Hospitalizations for vaccine preventable pneumonias in patients with inflammatory bowel disease: a 6-year analysis of the Nationwide Inpatient Sample. Clin Exp Gastroenterol. 2013;6:43\u20139.","journal-title":"Clin Exp Gastroenterol"},{"issue":"Suppl 2","key":"621_CR13","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/irv.12084","volume":"7","author":"CR Beck","year":"2013","unstructured":"Beck CR, McKenzie BC, Hashim AB, Harris RC, Zanuzdana A, Agboado G, et al. Influenza vaccination for immunocompromised patients: summary of a systematic review and meta-analysis. Influenza Other Respir Viruses. 2013;7(Suppl 2):72\u20135.","journal-title":"Influenza Other Respir Viruses"},{"issue":"4","key":"621_CR14","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.crohns.2012.05.011","volume":"7","author":"G Andrisani","year":"2013","unstructured":"Andrisani G, Frasca D, Romero M, Armuzzi A, Felice C, Marzo M, et al. Immune response to influenza A\/H1N1 vaccine in inflammatory bowel disease patients treated with anti TNF-alpha agents: effects of combined therapy with immunosuppressants. J Crohns Colitis. 2013;7(4):301\u20137.","journal-title":"J Crohns Colitis."},{"issue":"5","key":"621_CR15","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1136\/ard.2007.077552","volume":"67","author":"LB Gelinck","year":"2008","unstructured":"Gelinck LB, van der Bijl AE, Beyer WE, Visser LG, Huizinga TW, van Hogezand RA, et al. The effect of anti-tumour necrosis factor alpha treatment on the antibody response to influenza vaccination. Ann Rheum Dis. 2008;67(5):713\u20136.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"621_CR16","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.crohns.2013.08.008","volume":"8","author":"Y Hagihara","year":"2014","unstructured":"Hagihara Y, Ohfuji S, Watanabe K, Yamagami H, Fukushima W, Maeda K, et al. Infliximab and\/or immunomodulators inhibit immune responses to trivalent influenza vaccination in adults with inflammatory bowel disease. J Crohns Colitis. 2014;8(3):223\u201333.","journal-title":"J Crohns Colitis."},{"issue":"2","key":"621_CR17","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/ajg.2008.120","volume":"104","author":"Y Lu","year":"2009","unstructured":"Lu Y, Jacobson DL, Ashworth LA, Grand RJ, Meyer AL, McNeal MM, et al. Immune response to influenza vaccine in children with inflammatory bowel disease. Am J Gastroenterol. 2009;104(2):444\u201353.","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"621_CR18","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/ajg.2011.320","volume":"107","author":"GY Melmed","year":"2012","unstructured":"Melmed GY. Vaccinations while on thiopurines: some protection is better than none. Am J Gastroenterol. 2012;107(1):141\u20132.","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"621_CR19","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/ajg.2012.406","volume":"108","author":"MD Long","year":"2013","unstructured":"Long MD, Martin C, Sandler RS, Kappelman MD. Increased risk of pneumonia among patients with inflammatory bowel disease. Am J Gastroenterol. 2013;108(2):240\u20138.","journal-title":"Am J Gastroenterol"},{"key":"621_CR20","doi-asserted-by":"crossref","unstructured":"Kim DK, Bridges CB, Harriman KH, Advisory Committee on Immunization P. Advisory Committee on Immunization Practices recommended immunization schedule for adults aged 19 years or older: United States, 2016. Ann Intern Med 2016; 164(3):184\u2013194.","DOI":"10.7326\/M15-3005"},{"issue":"3","key":"621_CR21","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1097\/MIB.0000000000000615","volume":"22","author":"J de Bruyn","year":"2016","unstructured":"de Bruyn J, Fonseca K, Ghosh S, Panaccione R, Gasia MF, Ueno A, et al. Immunogenicity of influenza vaccine for patients with inflammatory bowel disease on maintenance infliximab therapy: a randomized trial. Inflamm Bowel Dis. 2016;22(3):638\u201347.","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"621_CR22","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1136\/gut.2010.233981","volume":"60","author":"JF Rahier","year":"2011","unstructured":"Rahier JF, Papay P, Salleron J, Sebastian S, Marzo M, Peyrin-Biroulet L, et al. H1N1 vaccines in a large observational cohort of patients with inflammatory bowel disease treated with immunomodulators and biological therapy. Gut. 2011;60(4):456\u201362.","journal-title":"Gut"},{"issue":"6","key":"621_CR23","first-page":"396","volume":"11","author":"JS Reich","year":"2015","unstructured":"Reich JS, Miller HL, Wasan SK, Noronha A, Ardagna E, Sullivan K, et al. Influenza and pneumococcal vaccination rates in patients with inflammatory bowel disease. Gastroenterol Hepatol (N Y). 2015;11(6):396\u2013401.","journal-title":"Gastroenterol Hepatol (N Y)"},{"issue":"22","key":"621_CR24","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1056\/NEJMe1505050","volume":"372","author":"JI Cohen","year":"2015","unstructured":"Cohen JI. A new vaccine to prevent herpes zoster. N Engl J Med. 2015;372(22):2149\u201350.","journal-title":"N Engl J Med"},{"issue":"40","key":"621_CR25","doi-asserted-by":"publisher","first-page":"11273","DOI":"10.3748\/wjg.v21.i40.11273","volume":"21","author":"AC Marin","year":"2015","unstructured":"Marin AC, Gisbert JP, Chaparro M. Immunogenicity and mechanisms impairing the response to vaccines in inflammatory bowel disease. World J Gastroenterol. 2015;21(40):11273\u201381.","journal-title":"World J Gastroenterol"},{"key":"621_CR26","doi-asserted-by":"crossref","unstructured":"\u2022 Farraye FA, Melmed GY, Lichtenstein GR, Kane SV. ACG Clinical Guideline: preventive care in inflammatory bowel disease. Am J Gastroenterol. 2017; 112(2):241\u201358. An up-to-date evidence-based guideline for all of the issues mentioned in this article.","DOI":"10.1038\/ajg.2016.537"},{"issue":"20","key":"621_CR27","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.1016\/j.vaccine.2017.03.080","volume":"35","author":"HY Jiang","year":"2017","unstructured":"Jiang HY, Wang SY, Deng M, Li YC, Ling ZX, Shao L, et al. Immune response to hepatitis B vaccination among people with inflammatory bowel diseases: a systematic review and meta-analysis. Vaccine. 2017;35(20):2633\u201341.","journal-title":"Vaccine"},{"issue":"8","key":"621_CR28","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1097\/00054725-200608000-00016","volume":"12","author":"GR Lichtenstein","year":"2006","unstructured":"Lichtenstein GR, Sands BE, Pazianas M. Prevention and treatment of osteoporosis in inflammatory bowel disease. Inflamm Bowel Dis. 2006;12(8):797\u2013813.","journal-title":"Inflamm Bowel Dis"},{"key":"621_CR29","doi-asserted-by":"crossref","unstructured":"Bernstein CN. Osteoporosis in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 2006; 4(2):152\u2013156.","DOI":"10.1016\/j.cgh.2005.10.014"},{"issue":"7","key":"621_CR30","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.amjmed.2009.01.022","volume":"122","author":"T Ali","year":"2009","unstructured":"Ali T, Lam D, Bronze MS, Humphrey MB. Osteoporosis in inflammatory bowel disease. Am J Med. 2009;122(7):599\u2013604.","journal-title":"Am J Med"},{"issue":"9","key":"621_CR31","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1111\/j.1572-0241.1998.468_q.x","volume":"93","author":"RD Pollak","year":"1998","unstructured":"Pollak RD, Karmeli F, Eliakim R, Ackerman Z, Tabb K, Rachmilewitz D. Femoral neck osteopenia in patients with inflammatory bowel disease. Am J Gastroenterol. 1998;93(9):1483\u201390.","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"621_CR32","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/ajg.2008.78","volume":"104","author":"B Shen","year":"2009","unstructured":"Shen B, Remzi FH, Oikonomou IK, Lu H, Lashner BA, Hammel JP, et al. Risk factors for low bone mass in patients with ulcerative colitis following ileal pouch-anal anastomosis. Am J Gastroenterol. 2009;104(3):639\u201346.","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"621_CR33","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.maturitas.2008.11.022","volume":"62","author":"J Compston","year":"2009","unstructured":"Compston J, Cooper A, Cooper C, Francis R, Kanis JA, Marsh D, et al. Guidelines for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK. Maturitas. 2009;62(2):105\u20138.","journal-title":"Maturitas"},{"issue":"10","key":"621_CR34","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1007\/s00198-014-2794-2","volume":"25","author":"F Cosman","year":"2014","unstructured":"Cosman F, de Beur SJ, LeBoff MS, Lewiecki EM, Tanner B, Randall S, et al. Clinician\u2019s guide to prevention and treatment of osteoporosis. Osteoporos Int. 2014;25(10):2359\u201381.","journal-title":"Osteoporos Int"},{"issue":"2","key":"621_CR35","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1093\/qjmed\/93.2.105","volume":"93","author":"TP van Staa","year":"2000","unstructured":"van Staa TP, Leufkens HG, Abenhaim L, Begaud B, Zhang B, Cooper C. Use of oral corticosteroids in the United Kingdom. QJM. 2000;93(2):105\u201311.","journal-title":"QJM"},{"issue":"6","key":"621_CR36","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1359\/jbmr.2000.15.6.993","volume":"15","author":"TP Van Staa","year":"2000","unstructured":"Van Staa TP, Leufkens HG, Abenhaim L, Zhang B, Cooper C. Use of oral corticosteroids and risk of fractures. J Bone Miner Res. 2000;15(6):993\u20131000.","journal-title":"J Bone Miner Res"},{"issue":"3","key":"621_CR37","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1111\/j.1572-0241.2007.01582.x","volume":"103","author":"S Kane","year":"2008","unstructured":"Kane S, Khatibi B, Reddy D. Higher incidence of abnormal Pap smears in women with inflammatory bowel disease. Am J Gastroenterol. 2008;103(3):631\u20136.","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"621_CR38","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1002\/ibd.20391","volume":"14","author":"S Kane","year":"2008","unstructured":"Kane S. Abnormal Pap smears in inflammatory bowel disease. Inflamm Bowel Dis. 2008;14(8):1158\u201360.","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"621_CR39","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1053\/j.gastro.2008.10.021","volume":"136","author":"H Singh","year":"2009","unstructured":"Singh H, Demers AA, Nugent Z, Mahmud SM, Kliewer EV, Bernstein CN. Risk of cervical abnormalities in women with inflammatory bowel disease: a population-based nested case-control study. Gastroenterology. 2009;136(2):451\u20138.","journal-title":"Gastroenterology"},{"issue":"2","key":"621_CR40","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.gtc.2012.01.006","volume":"41","author":"JA Sinclair","year":"2012","unstructured":"Sinclair JA, Wasan SK, Farraye FA. Health maintenance in the inflammatory bowel disease patient. Gastroenterol Clin N Am. 2012;41(2):325\u201337.","journal-title":"Gastroenterol Clin N Am"},{"issue":"4","key":"621_CR41","doi-asserted-by":"publisher","first-page":"e111","DOI":"10.1097\/AOG.0000000000001708","volume":"128","author":"Committee on Practice B-G","year":"2016","unstructured":"Committee on Practice B-G. Practice bulletin no. 168: cervical cancer screening and prevention. Obstet Gynecol. 2016;128(4):e111\u201330.","journal-title":"Obstet Gynecol"},{"issue":"3","key":"621_CR42","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1097\/MIB.0000000000000620","volume":"22","author":"A Mikocka-Walus","year":"2016","unstructured":"Mikocka-Walus A, Knowles SR, Keefer L, Graff L. Controversies revisited: a systematic review of the comorbidity of depression and anxiety with inflammatory bowel diseases. Inflamm Bowel Dis. 2016;22(3):752\u201362.","journal-title":"Inflamm Bowel Dis"},{"issue":"8","key":"621_CR43","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1097\/00054725-200608000-00004","volume":"12","author":"X Calvet","year":"2006","unstructured":"Calvet X, Gallardo O, Coronas R, Casellas F, Montserrat A, Torrejon A, et al. Remission on thiopurinic immunomodulators normalizes quality of life and psychological status in patients with Crohn's disease. Inflamm Bowel Dis. 2006;12(8):692\u20136.","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"621_CR44","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/ajg.2012.471","volume":"108","author":"AN Ananthakrishnan","year":"2013","unstructured":"Ananthakrishnan AN, Gainer VS, Cai T, Perez RG, Cheng SC, Savova G, et al. Similar risk of depression and anxiety following surgery or hospitalization for Crohn's disease and ulcerative colitis. Am J Gastroenterol. 2013;108(4):594\u2013601.","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"621_CR45","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.mcna.2017.03.010","volume":"101","author":"S Smithson","year":"2017","unstructured":"Smithson S, Pignone MP. Screening adults for depression in primary care. Med Clin North Am. 2017;101(4):807\u201321.","journal-title":"Med Clin North Am"},{"issue":"6","key":"621_CR46","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1002\/ibd.20068","volume":"13","author":"HC Deter","year":"2007","unstructured":"Deter HC, Keller W, von Wietersheim J, Jantschek G, Duchmann R, Zeitz M, et al. Psychological treatment may reduce the need for healthcare in patients with Crohn\u2019s disease. Inflamm Bowel Dis. 2007;13(6):745\u201352.","journal-title":"Inflamm Bowel Dis"},{"issue":"11","key":"621_CR47","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.1007\/s10620-006-9624-0","volume":"52","author":"SS Mahid","year":"2007","unstructured":"Mahid SS, Minor KS, Stevens PL, Galandiuk S. The role of smoking in Crohn\u2019s disease as defined by clinical variables. Dig Dis Sci. 2007;52(11):2897\u2013903.","journal-title":"Dig Dis Sci"},{"issue":"8","key":"621_CR48","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1023\/A:1010609722315","volume":"46","author":"HS Odes","year":"2001","unstructured":"Odes HS, Fich A, Reif S, Halak A, Lavy A, Keter D, et al. Effects of current cigarette smoking on clinical course of Crohn\u2019s disease and ulcerative colitis. Dig Dis Sci. 2001;46(8):1717\u201321.","journal-title":"Dig Dis Sci"},{"issue":"9","key":"621_CR49","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1038\/ajg.2012.196","volume":"107","author":"LM Higuchi","year":"2012","unstructured":"Higuchi LM, Khalili H, Chan AT, Richter JM, Bousvaros A, Fuchs CS. A prospective study of cigarette smoking and the risk of inflammatory bowel disease in women. Am J Gastroenterol. 2012;107(9):1399\u2013406.","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"621_CR50","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1093\/ecco-jcc\/jjv238","volume":"10","author":"M Severs","year":"2016","unstructured":"Severs M, van Erp SJ, van der Valk ME, Mangen MJ, Fidder HH, van der Have M, et al. Smoking is associated with extra-intestinal manifestations in inflammatory bowel disease. J Crohns Colitis. 2016;10(4):455\u201361.","journal-title":"J Crohns Colitis."},{"issue":"1","key":"621_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/03009742.2011.599073","volume":"41","author":"MK Soderlin","year":"2012","unstructured":"Soderlin MK, Petersson IF, Geborek P. The effect of smoking on response and drug survival in rheumatoid arthritis patients treated with their first anti-TNF drug. Scand J Rheumatol. 2012;41(1):1\u20139.","journal-title":"Scand J Rheumatol"},{"issue":"1","key":"621_CR52","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/ibd.22959","volume":"19","author":"T Nunes","year":"2013","unstructured":"Nunes T, Etchevers MJ, Merino O, Gallego S, Garcia-Sanchez V, Marin-Jimenez I, et al. Does smoking influence Crohn\u2019s disease in the biologic era? The TABACROHN study. Inflamm Bowel Dis. 2013;19(1):23\u20139.","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"621_CR53","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1111\/apt.12176","volume":"37","author":"A Gustavsson","year":"2013","unstructured":"Gustavsson A, Magnuson A, Blomberg B, Andersson M, Halfvarson J, Tysk C. Smoking is a risk factor for recurrence of intestinal stricture after endoscopic dilation in Crohn\u2019s disease. Aliment Pharmacol Ther. 2013;37(4):430\u20137.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1\u20132","key":"621_CR54","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1159\/000442930","volume":"34","author":"J Cosnes","year":"2016","unstructured":"Cosnes J. Smoking and diet: impact on disease course? Dig Dis. 2016;34(1\u20132):72\u20137.","journal-title":"Dig Dis"},{"issue":"7","key":"621_CR55","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1111\/apt.12440","volume":"38","author":"T Nunes","year":"2013","unstructured":"Nunes T, Etchevers MJ, Domenech E, Garcia-Sanchez V, Ber Y, Penalva M, et al. Smoking does influence disease behaviour and impacts the need for therapy in Crohn\u2019s disease in the biologic era. Aliment Pharmacol Ther. 2013;38(7):752\u201360.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"621_CR56","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1097\/01.MIB.0000436959.62286.f9","volume":"20","author":"AV Marzano","year":"2014","unstructured":"Marzano AV, Borghi A, Stadnicki A, Crosti C, Cugno M. Cutaneous manifestations in patients with inflammatory bowel diseases: pathophysiology, clinical features, and therapy. Inflamm Bowel Dis. 2014;20(1):213\u201327.","journal-title":"Inflamm Bowel Dis"},{"issue":"9","key":"621_CR57","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1111\/apt.12491","volume":"38","author":"GW Moran","year":"2013","unstructured":"Moran GW, Lim AW, Bailey JL, Dubeau MF, Leung Y, Devlin SM, et al. Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease. Aliment Pharmacol Ther. 2013;38(9):1002\u201324.","journal-title":"Aliment Pharmacol Ther"},{"key":"621_CR58","doi-asserted-by":"crossref","unstructured":"Sifuentes H, Kane S. Monitoring for extra-intestinal cancers in IBD. Curr Gastroenterol Rep 2015; 17 (11):42.","DOI":"10.1007\/s11894-015-0467-8"},{"key":"621_CR59","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1097\/MIB.0000000000001191","volume":"23","author":"LHC Nissen","year":"2017","unstructured":"Nissen LHC, Pierik M, Derikx L, de Jong E, Kievit W, van den Heuvel TRA, et al. Risk factors and clinical outcomes in patients with IBD with melanoma. Inflamm Bowel Dis. 2017;23:2018\u201326.","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"621_CR60","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1159\/000338144","volume":"30","author":"L Beaugerie","year":"2012","unstructured":"Beaugerie L. Immunosuppression-related lymphomas and cancers in IBD: how can they be prevented? Dig Dis. 2012;30(4):415\u20139.","journal-title":"Dig Dis"},{"key":"621_CR61","unstructured":"Reasons Reported by Medicare Beneficiaries for Not Receiving Influenza and Pneumococcal Vaccinations -- United States, 1996. https:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/mm4839a4.htm. Accessed 2 Oct, 2017."},{"key":"621_CR62","unstructured":"Pneumococcal Vaccine Recommendations | Vaccines and Immunizations | CDC. https:\/\/www.cdc.gov\/vaccines\/vpd\/pneumo\/hcp\/recommendations.html. Accessed 2 Oct 2017."},{"key":"621_CR63","unstructured":"ACIP Pneumococcal Vaccine Recommendations | CDC. https:\/\/www.cdc.gov\/vaccines\/hcp\/acip-recs\/vacc-specific\/pneumo.html. Accessed 2 Oct 2017."}],"container-title":["Current Gastroenterology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11894-018-0621-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-018-0621-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-018-0621-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T10:11:00Z","timestamp":1659089460000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11894-018-0621-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,17]]},"references-count":63,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["621"],"URL":"https:\/\/doi.org\/10.1007\/s11894-018-0621-1","relation":{},"ISSN":["1522-8037","1534-312X"],"issn-type":[{"value":"1522-8037","type":"print"},{"value":"1534-312X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,17]]},"assertion":[{"value":"17 April 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Guidelines"}},{"value":"Sunanda Kane reports working as a consultant to AbbVie, Janssen, and Seres and received research funding from UCB. Fazia Mir declares no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"23"}}